Adverse drug-event detection using the tree-based scan statistics (TreeScan) and comparison with common mining methods: new user, propensity score-matched cohorts
European Journal of Clinical Pharmacology · 2026
DOI: 10.1007/s00228-025-03945-0 ↗Kurz gefasst
Vergleichsstudie in der Zeitschrift European Journal of Clinical Pharmacology, 2026. Verfasst von Hailong Li und 5 weiteren Autor:innen. Beteiligte Einrichtung: Department of Pharmacy/Evidence-Based Pharmacy Center, West China Second University Hospital, Sichuan University, Chengdu, China. Hauptthemen laut MEDLINE: Hydroxymethylglutaryl-CoA Reductase Inhibitors, Data Mining, Drug-Related Side Effects and Adverse Reactions, Adverse Drug Reaction Reporting Systems. Die Arbeit nennt 21 Literaturangaben. Gefördert von: National Natural Science Foundation of China, The Key Research Project of Sichuan Province.
Abstract (Originalsprache)
PURPOSE: Tree-based scan statistics (TreeScan) combined with a new user propensity score (PS)-matched cohort design (PS-TreeScan) enhances post-marketing drug safety surveillance by adjusting for confounding biases. However, this method has not been compared with other signal mining techniques or used in post-marketing drug safety studies in China. We evaluate the effectiveness of the PS-TreeScan method in identifying statin-associated adverse events (AEs) by comparing it with three established signal detection methods using a Chinese real-world database. METHODS: We used data from the Yinzhou District Medical Database, encompassing patients with hypertension (2010–2016). Statin exposure and AEs were determined via outpatient/inpatient prescriptions and using ICD-10 codes in similar settings, respectively. A new user design with a 1:1 PS matching was implemented. Standard positive and negative signals were obtained from published systematic reviews, meta-analyses, and summary of product characteristics (SPC). PS-TreeScan was compared with three mining methods—incident rate ratio (crude cohort), Bayesian Confidence Propagation Neural Network (BCPNN), and Gamma Poisson Shrinker (GPS)—to identify statin-related AEs. Evaluation indices were calculated using the diagnostic test evaluation method, and area under the receiver operating characteristic curve (AUC) values were compared to assess differences. RESULTS: PS-TreeScan identified 15 positive signals (P < 0.05), including 8 true positives. PS-TreeScan’s sensitivity was equivalent to those of BCPNN and GPS (62%) but higher than that of the crude cohort method. TreeScan AUC values were significantly higher at 77.7% (95% confidence interval: 63.7%–91.6%). CONCLUSION: Compared to the original data, matched data effectively reduced false positives and improved the AUC for all methods. The PS-TreeScan method outperformed the traditional methods, thus it is able to supplement other mining methods for active adverse drug reaction monitoring.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Pharmacy/Evidence-Based Pharmacy Center, West China Second University Hospital, Sichuan University, Chengdu, China.
- Children's Medicine Key Laboratory of Sichuan Province, Chengdu, China.
- Key Laboratory of Birth Defects and Related Diseases of Women and Children, Sichuan University, Ministry of Education, Chengdu, China.
- Research Center of Clinical Epidemiology, Peking University Third Hospital, Beijing, China.
- Key Laboratory of Epidemiology of Major Diseases (Peking University), Ministry of Education, Beijing, China.
- Yinzhou District Center for Disease Control and Prevention, Ningbo, China.
Förderung
- National Natural Science Foundation of China
- The Key Research Project of Sichuan Province
Zitieren
APA
Li, H., Zhao, H., Lin, H., Shen, P., Zhang, L., & Zhan, S. (2026). Adverse drug-event detection using the tree-based scan statistics (TreeScan) and comparison with common mining methods: new user, propensity score-matched cohorts. European Journal of Clinical Pharmacology. https://doi.org/10.1007/s00228-025-03945-0
Vancouver
Li H, Zhao H, Lin H, Shen P, Zhang L, Zhan S. Adverse drug-event detection using the tree-based scan statistics (TreeScan) and comparison with common mining methods: new user, propensity score-matched cohorts. European Journal of Clinical Pharmacology. 2026. doi:10.1007/s00228-025-03945-0
BibTeX
@article{Li2026,
author = {Li, Hailong and Zhao, Houyu and Lin, Hongbo and Shen, Peng and Zhang, Lingli and Zhan, Siyan},
title = {Adverse drug-event detection using the tree-based scan statistics (TreeScan) and comparison with common mining methods: new user, propensity score-matched cohorts},
journal = {European Journal of Clinical Pharmacology},
year = {2026},
doi = {10.1007/s00228-025-03945-0}
}
EUVIMED